Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 360.10
-3.10 (-0.85%)
Nov 12, 2026, 3:29 PM IST
Ind-Swift Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 7,641 | 6,491 | 5,742 | 17,091 | 12,073 | 10,387 |
Other Revenue | -0 | - | - | - | 86.24 | 141.74 |
| 7,641 | 6,491 | 5,742 | 17,091 | 12,159 | 10,529 | |
Revenue Growth | 33.64% | 13.04% | -66.40% | 40.56% | 15.48% | 16.11% |
Cost of Revenue | 3,221 | 2,880 | 2,880 | 8,698 | 6,556 | 5,374 |
Gross Profit | 4,420 | 3,611 | 2,863 | 8,393 | 5,604 | 5,155 |
Selling, General & Admin | 1,549 | 1,462 | 1,252 | 2,475 | 1,401 | 1,278 |
Other Operating Expenses | 1,778 | 1,679 | 1,680 | 2,856 | 1,814 | 1,642 |
Operating Expenses | 3,650 | 3,447 | 3,176 | 6,135 | 3,788 | 4,231 |
Operating Income | 769.09 | 163.74 | -313.32 | 2,259 | 1,815 | 924.23 |
Interest Expense | - | -1.94 | -13.83 | -977.96 | -863.93 | -914.53 |
Interest & Investment Income | 564.26 | 554.92 | 382.69 | 100.49 | 58.72 | 5.62 |
Earnings From Equity Investments | 2.1 | 0.98 | -0.52 | -4.9 | -2.34 | - |
Currency Exchange Gain (Loss) | - | - | - | 163.5 | 180.87 | 147.63 |
Other Non Operating Income (Expenses) | -153.41 | -97.36 | 271.96 | 121.22 | -48.57 | 99.03 |
EBT Excluding Unusual Items | 1,182 | 620.34 | 326.98 | 1,661 | 1,140 | 261.99 |
Gain (Loss) on Sale of Investments | - | - | - | 434.71 | - | - |
Gain (Loss) on Sale of Assets | -1.73 | -1.73 | 18.44 | -28.41 | -0.61 | -65.66 |
Asset Writedown | - | - | - | - | -10 | -71.01 |
Other Unusual Items | -118.22 | -110.06 | 2,232 | 3,910 | -266.48 | - |
Pretax Income | 1,062 | 508.55 | 2,577 | 5,977 | 862.87 | 125.33 |
Income Tax Expense | 209.42 | 77.3 | 72.7 | 589.81 | 386.9 | 146.82 |
Net Income | 852.67 | 431.25 | 2,505 | 5,388 | 475.97 | -21.49 |
Net Income to Common | 852.67 | 431.25 | 2,505 | 5,388 | 475.97 | -21.49 |
Net Income Growth | -63.49% | -82.78% | -53.51% | 1031.91% | - | - |
Shares Outstanding (Basic) | 87 | 84 | 67 | 59 | 59 | 59 |
Shares Outstanding (Diluted) | 88 | 86 | 71 | 59 | 59 | 59 |
Shares Change | 12.35% | 20.40% | 20.41% | - | - | - |
EPS (Basic) | 9.80 | 5.16 | 37.24 | 91.18 | 8.06 | -0.36 |
EPS (Diluted) | 9.73 | 5.03 | 35.21 | 91.18 | 8.06 | -0.36 |
EPS Growth | -67.52% | -85.71% | -61.38% | 1031.91% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -2,103 | -1,559 | -930.96 | -2,600 | 1,818 | 1,319 |
Free Cash Flow Per Share | -24.01 | -18.20 | -13.09 | -44.00 | 30.78 | 22.32 |
Gross Margin | 57.84% | 55.63% | 49.85% | 49.11% | 46.08% | 48.96% |
Operating Margin | 10.06% | 2.52% | -5.46% | 13.21% | 14.93% | 8.78% |
Profit Margin | 11.16% | 6.64% | 43.62% | 31.52% | 3.91% | -0.20% |
Free Cash Flow Margin | -27.52% | -24.02% | -16.21% | -15.21% | 14.95% | 12.52% |
EBITDA | 1,068 | 445.18 | -68.7 | 3,063 | 2,389 | 2,235 |
EBITDA Margin | 13.97% | 6.86% | -1.20% | 17.92% | 19.64% | 21.22% |
D&A For EBITDA | 298.44 | 281.44 | 244.62 | 804.1 | 573.39 | 1,310 |
EBIT | 769.09 | 163.74 | -313.32 | 2,259 | 1,815 | 924.23 |
EBIT Margin | 10.06% | 2.52% | -5.46% | 13.21% | 14.93% | 8.78% |
Effective Tax Rate | 19.72% | 15.20% | 2.82% | 9.87% | 44.84% | 117.15% |
Revenue as Reported | 8,055 | 6,961 | 6,431 | 17,975 | 12,408 | 10,822 |
Advertising Expenses | - | 50.74 | 60.16 | 84.09 | 34.92 | 2.36 |